Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014)
Tandem Diabetes Care's (TNDM) quarterly Non Operating Investment Income came in at $6529.0 in Q3 2014, up 520.95% on a QoQ basis from -$1551.0 in Q2 2014.
Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014) Analysis & Trends
Tandem Diabetes Care (TNDM) has 1 years of Non Operating Investment Income data on file, last reported at $6529.0 in Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | - |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Tandem Diabetes Care | 1.58 Bn | 1.13 Bn | 144.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 6,529.00 |
| Sep 30, 2014 | 6,529.00 |
| Jun 30, 2014 | -1,551.00 |
| Jun 30, 2014 | -1,551.00 |
| Mar 31, 2014 | 13,833.00 |
| Mar 31, 2014 | 13,833.00 |